InsidersTradesSigma
Track the 제이투케이바이오 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Chemicals sector, 제이투케이바이오 has logged 3 reports. Market capitalisation: €60.9bn. The latest transaction was reported on 26 August 2026 (Sale). Among the most active insiders: 배준태. The full history is free.
3
Insider Decl.
n/a
Thresholds
€21,390
1 ops.
Buy Volume
n/a
2 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,119 of 29,062 companies
59.1
score / 100
Value49
Quality69
FCF yld1.5%
Earn yld4.2%
EV/EBITDA14.0x
ROE12%
Gross mgn39%
Net mgn8.1%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 August 2026
关于 제이투케이바이오
J2K Bio 是一家在 XKRX 上市的化学和材料领域的公司。它专注于生物技术解决方案的开发。